Evidence map›Paper›PMID 25902531›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Noninvasive imaging of immune responses.

Mohammad Rashidian, Edmund J Keliher, Angelina M Bilate, Joao N Duarte, Gregory R Wojtkiewicz, Johanne Tracey Jacobsen, Juanjo Cragnolini, Lee Kim Swee, Gabriel D Victora, Ralph Weissleder and 1 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 134 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
134citing papers in PubMed, 1 pooled it
15.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

134 citing papers in PubMed, 1 synthesis or guideline pooled it, 220 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Can Nuclear Imaging Detect Trained Immunity in Cardiovascular Disease?Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Engineered Antibodies as Cancer Radiotheranostics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Site-Specifically Conjugated Single-Domain Antibody Successfully Identifies Glypican-3-Expressing Liver Cancer by Immuno-PET.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article

74 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mohammad RashidianWhitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142;
Edmund J KeliherCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114; Department of Radiology, Massachusetts General Hospital, Boston, MA 02114;
Angelina M BilateWhitehead Institute for Biomedical Research, Cambridge, MA 02142;
Joao N DuarteWhitehead Institute for Biomedical Research, Cambridge, MA 02142;
Gregory R WojtkiewiczCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114;
Johanne Tracey JacobsenWhitehead Institute for Biomedical Research, Cambridge, MA 02142; Center for Immune Regulation, Oslo University Hospital, University of Oslo, N-0372 Oslo, Norway;
Juanjo CragnoliniWhitehead Institute for Biomedical Research, Cambridge, MA 02142;
Lee Kim SweeWhitehead Institute for Biomedical Research, Cambridge, MA 02142;
Gabriel D VictoraWhitehead Institute for Biomedical Research, Cambridge, MA 02142;
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Boston, MA 02114; Department of Radiology, Massachusetts General Hospital, Boston, MA 02114; and Department of Systems Biology, Harvard Medical School, Boston, MA 02115.
Hidde L PloeghWhitehead Institute for Biomedical Research, Cambridge, MA 02142; Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142; ploegh@wi.mit.edu.
Whitehead Institute for Biomedical Research · USCenter for Systems Biology · USMassachusetts Institute of Technology · USMassachusetts General Hospital · USOslo University Hospital · NO

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Andreea O'Connell · 1985 to 2026
$93.9M
A new strategy to disrupt protein-protein interactions in eukaryotic cells.DP1GM106409 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2012 to 2016
$4.8M
Sortase-mediated protein engineering for the study of host-pathogen interactionsR01AI087879 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2010 to 2019
$4.5M
Endosomal TLRs and their accessory proteins: cell biology and biochemistryR01GM100518 · NIGMS · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2012 to 2015
$1.5M
Non-invasive imaging of the immune response based on the use of isotopically labeled single domain antibody fragmentsR21AI117373 · NIAID · WHITEHEAD INSTITUTE FOR BIOMEDICAL RES · PI PLOEGH, HIDDE L. · 2015 to 2016
$536k
NCCDPHP CDC HHS DP1-GM106409-03NCI NIH HHS P30 CA014051NIAID NIH HHS NIH R01-AI087879-06NIAID NIH HHS R01 AI087879NIAID NIH HHS R21 AI117373NIGMS NIH HHS DP1 GM106409NIGMS NIH HHS R01 GM100518NIGMS NIH HHS R01-GM100518-04
6 · The paper itself

Abstract

At their margins, tumors often contain neutrophils, dendritic cells, and activated macrophages, which express class II MHC and CD11b products. The interplay between stromal cells, tumor cells, and migratory cells such as lymphocytes creates opportunities for noninvasive imaging of immune responses. We developed alpaca-derived antibody fragments specific for mouse class II MHC and CD11b products, expressed on the surface of a variety of myeloid cells. We validated these reagents by flow cytometry and two-photon microscopy to obtain images at cellular resolution. To enable noninvasive imaging of the targeted cell populations, we developed a method to site-specifically label VHHs [the variable domain (VH) of a camelid heavy-chain only antibody] with (18)F or (64)Cu. Radiolabeled VHHs rapidly cleared the circulation (t1/2 ≈ 20 min) and clearly visualized lymphoid organs. We used VHHs to explore the possibility of imaging inflammation in both xenogeneic and syngeneic tumor models, which resulted in detection of tumors with remarkable specificity. We also imaged the infiltration of myeloid cells upon injection of complete Freund's adjuvant. Both anti-class II MHC and anti-CD11b VHHs detected inflammation with excellent specificity. Given the ease of manufacture and labeling of VHHs, we believe that this method could transform the manner in which antitumor responses and/or infectious events may be tracked.

Indexed as

Positron-Emission TomographyAminoacyltransferasesAnimalsAntibodiesAntineoplastic AgentsBacterial ProteinsBone Marrow CellsCopper RadioisotopesCysteine EndopeptidasesFlow CytometryFluorine RadioisotopesFreund's AdjuvantHistocompatibility Antigens Class IIHumansImmune SystemImmunoglobulin Heavy ChainsAminoacyltransferasesAntibodiesAntineoplastic AgentsBacterial ProteinsCopper RadioisotopesCysteine EndopeptidasesFluorine RadioisotopesFreund's AdjuvantHistocompatibility Antigens Class IIImmunoglobulin Heavy Chainssortase Acamelid single domain antibodiescancerinflammationnon-invasive imagingPET imaging

Identifiers

PMID25902531
PMCPMC4434737
OpenAlexW1997730366

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.